A meta-analysis that surfaced contradictions a manual review would miss

Dr. Kaushik is a practicing pulmonologist at a medical college with 15 years of experience, researching COPD, asthma, ILD, and related respiratory conditions alongside active clinical practice.

He was managing hundreds of papers for a meta-analysis on COPD-related cardiac co-morbidities, losing 3-4 hours a day just organizing and finding studies. Staying current while seeing patients meant comprehensive synthesis of contradictory findings was the first thing to slip.

Paperguide handles the two heaviest parts of his review work, building a structured overview across many studies, and extracting comparable data from the ones that matter, so his time goes to interpretation and clinical judgment.

Dr. Kaushik’s hardest review was a meta-analysis on COPD-related cardiac co-morbidities, and later a systematic review for pulmonary hypertension clinical guidelines, the kind of work where missing a contradictory study doesn’t just cost time, it weakens the conclusion. As a clinician, he was losing three to four hours a day just organizing papers and finding the relevant ones, before any actual analysis began.

He started handing the synthesis to Paperguide. For a question like “the effectiveness of corticosteroid tapering strategies in severe COPD patients,” Deep Research Report pulled together a structured overview across more than forty studies, comparing the different tapering protocols and, crucially, flagging where the studies disagreed with each other. That contradiction-surfacing turned out to be the feature that changed his output: findings that cut against the consensus, the kind a hurried manual read glides past, were put in front of him, and they led to a genuinely more nuanced discussion section in his paper than he would otherwise have written. For the trials that mattered most, he extracted the comparable data, patient demographics, dosing regimens, adverse events, into a structured form for the meta-analysis, rather than transcribing them by hand.

The time savings are real, weekly research time roughly halved, and a pulmonary-hypertension guideline review that would have taken three months done in six weeks, but the part he emphasizes is quality, not speed. Being current with the latest evidence, and seeing the contradictions in it, makes him a better clinician in the room with a patient, not just a faster author.